Exploring porcine kidney explants as a model for the study of nephrotoxins and the therapeutic potential of phytic acid

Environ Toxicol Pharmacol. 2023 Sep:102:104241. doi: 10.1016/j.etap.2023.104241. Epub 2023 Aug 9.

Abstract

The use of in vivo models to assess nephrotoxicity has faced ethical limitations. A viable alternative is the ex vivo model that combines the 3 R principles with the preservation of tissue histology. Here, we established a gentamicin nephrotoxicity model using pigs` kidney explants and investigated the effect of phytic acid (IP6) against gentamicin- induced nephrotoxicity. A total of 360 kidney explants were divided into control, gentamicin (10 mM), IP6 (5 mM), and gentamicin+IP6 groups. The activity of gammaglutamyltransferase (GGT), creatinine levels, histological assessment, oxidative stress, and inflammatory cytokine expression were analyzed. Exposure to gentamicin induced an increase in GGT activity, creatinine levels, lesion score, lipoperoxidation and IL-8 expression. Explants exposed to IP6 remained like the control. The addition of IP6 to gentamicin prevented tissue damage, increasing the antioxidant status and gene expression of IL-10. This model proved to be an adequate experimental approach for identifying nephrotoxins and potential products to modulate the toxicity.

Keywords: Ex vivo model disease; Inflammation; Porcine kidney explants; Renal toxicity.

MeSH terms

  • Animals
  • Antioxidants / metabolism
  • Antioxidants / pharmacology
  • Antioxidants / therapeutic use
  • Creatinine
  • Gentamicins / toxicity
  • Kidney
  • Kidney Diseases* / pathology
  • Oxidative Stress
  • Phytic Acid / metabolism
  • Phytic Acid / pharmacology
  • Phytic Acid / therapeutic use
  • Renal Insufficiency*
  • Swine

Substances

  • Phytic Acid
  • Creatinine
  • Antioxidants
  • Gentamicins